Protodynamic therapy for bladder cancer: in vitro results of a novel treatment concept




Laihia JK, Pylkkanen L, Laato M, Bostrom PJ, Leino L

PublisherWILEY-BLACKWELL PUBLISHING, INC

2009

 BJU International

BJU INTERNATIONAL

BJU INT

104

9

1233

1238

6

1464-4096

DOIhttps://doi.org/10.1111/j.1464-410X.2009.08611.x



cis-UCA is a potent antiproliferative agent in bladder cancer cell cultures. As our previous non-clinical studies showed that cis-UCA is locally and systemically well tolerated, protodynamic therapy with cis-UCA is a promising intravesical treatment for bladder cancer.



Last updated on 26/11/2024 10:05:46 PM